Supply Life-Changing Therapies from Clinic to Commercialization, Through Effective Scale Up, CoGs Management & Digital Solutions to Improve the Patient Experience
In 2025, cell and gene therapy reached a pivotal moment. Amid rising tariffs, shifting regulations, and capacity constraints, the industry gained clarity on what it takes to scale successfully. As a result, the focus on scaling novel therapies safely and efficiently has never been stronger, introducing a new era of operational excellence and expanded patient access.
As we enter 2026, AI, digitalization, and IoT are transforming how cell and gene therapies are planned, tracked, and delivered end-to-end. With smarter, data-driven decision-making, supply chain teams can better navigate tariff fluctuations, manufacturing variability, and regulatory complexity.
Designed by and for supply chain leaders across biopharma, including Roche, Bristol Myers Squibb, Johnson & Johnson, Genentech, ProKidney, and Vyriad the 7th Supply Chain & Logistics for Cell & Gene Therapy Summit delivers best-in-class perspectives on global patient supply, cost of goods optimization, and accelerating clinical and commercial programs through digital innovation. With strong end-to-end focus, the agenda reflects the real challenges facing advanced therapy supply chains today.
If you are a supply chain leader in cell and gene therapy, this is your must-attend opportunity to connect with peers, benchmark best practices, and gain actionable insights to build a resilient, future-ready supply chain that delivers therapies to patients, reliably and at scale.
Reducing complexity in supply chain and logistics is important now because our systems, therapies, and expectations have evolved - but many of our operational processes have not. Reducing complexity is no longer optional; it’s essential to delivering safe, high‑quality, reliable care in a resource‑constrained, fast‑moving clinical environment.
Sherry Kallingal, Senior Director, Operational Excellence, ProKidney
Being in a room full of passionate experts, sharing ideas and best practices, is a powerful catalyst for innovation. Hearing about the incredible work others are doing and learning new approaches inspires me to think about how we can collectively shape the future of our field. Ultimately, these collaborations help us find better ways to serve patients, and that’s what motivates me most
Oscar Monroy, Senior Manager, Supply Chain Process Management, Bristol Myers Squibb
This is the one conference I would not miss. It's the only place where you can have deep, nuanced discussions specific to cell and gene therapy supply chains - the complexities of COI/COC implementation, autologous patient logistics, phase-appropriate digital systems, and regulatory challenges that are unique to our industry. Last year's conversations on ISBT traceability, commercial transition planning, and supplier qualification were very insightful. I'm looking forward to 2026 to share our lessons learned and collaborate with the peers who truly understand the operational realities of scaling CGT supply chains.
Sherry Kallingal, Senior Director, Operational Excellence, ProKidney
Explore the Full Event Guide
- 19 senior supply chain and logistics leaders from pharma, biotech, and clinical sites sharing real-world strategies
- End-to-end coverage from clinic to commercialization, with practical insights into effective scale-up, cost management, and digital transformation
- Targeted networking with decision-makers through expert panels, roundtables, and structured sessions
- Case-study driven presentations across modalities and stages, from early clinical supply to commercial operations
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Dive into a highly practical program packed with real-world solutions to today’s most pressing supply chain and logistics challenges. Learn from case-study driven sessions covering topics like digitalization, regulatory navigation, cross-functional collaboration, allogeneic advances, and effective scale up from clinical to commercialization
Partner With Us
Position your solutions at the centre of industry decision-making as pharma and biotech actively evaluate digital cell orchestration platforms, courier and logistics partners, blood banks and apheresis sites, consultancy firms and CDMOs to accelerate their supply of advanced therapies
Join Biopharma Experts
Connect with senior experts from leading biopharma companies and clinical sites through focused workshops, expert panels, and structured networking to spark meaningful scientific and commercial conversations